- Country: Ukraine
- Summary: L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Hydrocortisone / Oxytetracycline Hydrochloride, Ointment, 10 Mg/G / 30 Mg/G, 15 G Each; Dexamethasone, Solution for Injection 4Mg/Ml; Empagliflozin Tablets...
- UAT Ref No: 129159716
- Deadline: 01 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 170000
- Notice Type: Tender
- Document Ref. No.: UA-2025-10-29-009476-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- L-lysine escinate, solution for injection, 1 mg/ml, 5 ml each; Hydrocortisone / oxytetracycline hydrochloride, ointment, 10 mg/g / 30 mg/g, 15 g each; Dexamethasone, solution for injection 4mg/ml; Empagliflozin film-coated tablets, 10 mg each; Dobutamine solution for infusions, 250 mg/50 ml, 50 ml each; Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule; Acetylsalicylic acid tablets 75 mg; Quetiapine, film-coated tablets, 25 mg each; Linezolid solution for infusions, 2 mg/ml in 300 ml; Loperamide 2 mg tablets/capsules; Loratadine 10 mg tablets; Mannitol solution for infusions 150 mg/ml 200 ml; meropenem, powder for injections/infusions, 1 g each; Moxifloxacin solution for infusions, 400 mg/250 ml, 250 ml each; Naloxone solution for injection, 0.4 mg/ml in 1 ml; Bupivacaine, solution for injection, 2.5 mg/ml in 200 ml; Octreotide solution for injection 0.1 mg/ml in 1 ml; Pregabalin, capsules, 75 mg each; Dexketoprofen solution for injections of 25 mg/ml in 2 ml increments; Decametoxin, solution, 0.2 mg/ml, 200 ml each; Thiamine chloride (vitamin B1), solution for injection, 50 mg/ml, 1 ml each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.4 ml each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.2 ml each; fluconazole, solution for infusions, 2 mg/ml, 100 ml each; Furosemide, solution for injection, 10 mg/ml, 2 ml each; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 5.0 ml each; Lidocaine, solution for injection, 100 mg/ml, 2 ml each
Purchase type: Goods
DK 021:2015:33600000-6: Pharmaceutical products
L-lysine escinate, solution for injection, 1 mg/ml, 5 ml each, Hydrocortisone / oxytetracycline hydrochloride, ointment, 10 mg/g / 30 mg/g, 15 g each, Dexamethasone, solution for injection 4 mg/ml, Empagliflozin film-coated tablets, 10 mg each, Dobutamine solution for infusions, 250 mg/50 ml, 50 ml each, Drotaverin solution for injection 20 mg/ml, 2 ml in an ampoule, Acetylsalicylic aci... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINL-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Hydrocortisone / Oxytetracycline Hydrochloride, Ointment, 10 Mg/G / 30 Mg/G, 15 G Each; Dexamethasone, Solution for Injection 4Mg/Ml; Empagliflozin Tablets... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "CHERNOOSTRIVSKA HOSPITAL OF THE CHRONOOSTRIVSKY VILLAGE COUNCIL, a Government sector organization in Ukraine, has announced a new tender for L-Lysine Escinate, Solution for Injection, 1 Mg/Ml, 5 Ml Each; Hydrocortisone / Oxytetracycline Hydrochloride, Ointment, 10 Mg/G / 30 Mg/G, 15 G Each; Dexamethasone, Solution for Injection 4Mg/Ml; Empagliflozin Tablets.... This tender is published on UkraineTenders under UAT Ref No: 129159716 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-01.
The estimated tender value is UAH 170000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
